Several studies suggest GLP-1 drugs may lower cancer risk. But that benefit may be due to the patients themselves: those who are healthier, wealthier and with better access to care.
- Clinical Epidemiologist, Washington University in St. Louis
Com os medicamentos GLP-1 se tornando mais acessíveis e baratos, eles também podem estar ao alcance de muitas pessoas para tratamento da dependência química
Los fármacos GLP-1 son los primeros medicamentos que se muestran prometedores para tratar la adicción a una amplia gama de sustancias.
GLP-1 drugs are the first medication to show promise for treating addiction to a wide range of substances.
Les médicaments GLP-1 sont efficaces pour traiter le diabète et l’obésité. Ils pourraient l’être aussi pour lutter contre de nombreuses autres affections. Néanmoins, des effets indésirables existent.
Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health conditions.
Un nombre croissant d’études indique que l’infection par le coronavirus SARS-CoV-2, même lorsqu’elle ne s’accompagne pas de symptômes sévères, peut avoir des conséquences délétères pour le cerveau.
Um novo estudo descobriu que os riscos de desenvolver COVID-19 longa diminuíram nos dois primeiros anos da pandemia. No entanto, adultos não vacinados tinham duas vezes mais chances de contrair a COVID-19 longa em comparação com aqueles que foram vacinados.
A new study finds the risks of developing long COVID declined over the first two years of the pandemic. But unvaccinated adults were more than twice as likely to get long COVID compared with those who were vaccinated.
Two new high-profile studies add to the increasingly worrisome picture of how even mild cases of COVID-19 can have detrimental effects on brain health.
A promising collection of studies suggests taking antivirals such as Paxlovid during an infection could reduce the risk of developing long COVID.
Contact Ziyad for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: St. Louis, Missouri, U.S.
- Website
- X (formerly Twitter): @zalaly
- Article Feed
- ORCID
- Joined
